Clinical trial
Levels of Serum Resistin in Asthmatics as a Potential Marker of Systemic Inflammation and Disease State.
NCT00339703 is registered in ClinicalTrials.gov with 59th Medical Wing as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Levels of Serum Resistin in Asthmatics as a Potential Marker of Systemic Inflammation and Disease State.
- Lead sponsor
- 59th Medical Wing
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2004
- Completion date
- May 31, 2006
- Enrollment
- 44 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.